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ABSTRAC-f  Culture conditions that favor rapid  multiplication of  human  umbilical vein endo- 
thelial cells (HUV-EC)  also support long-term serial propagation of the cells. This is routinely 
achieved when  HUV-EC  are grown  in  Medium  t99  (M-199)  supplemented  with  fetal  bovine 
serum (FBS) and endothelial cell growth factor (ECGF), on a human fibronectin  (HFN)  matrix. 
The HUV-EC can shift from  a proliferative to an organized state when the in vitro conditions 
are  changed  from  those favoring  low  density  proliferation  to  those supporting  high  density 
survival. When ECGF and HFN are omitted, cultures fail to achieve confluence beyond the first 
or  second  passage: the  preconfluent  cultures  organize  into  tubular structures after  4-6 wk. 
Some tubes become grossly visible and float in the culture medium, remaining tethered to the 
plastic dish at either end of the tube. On an ultrastructural level, the tubes consist of cells, held 
together  by junctional  complexes,  arranged  so as to  form  a  lumen.  The smallest  lumens are 
formed  by one cell folding over to form  a junction with itself. The cells contain WeibeI-Palade 
bodies and factor VIII-related  antigen. The lumens contain granular, fibrillar and amorphous 
debris.  Predigesting  the  HFN  matrix  with  trypsin  (10  min,  37°C)  or  plasmin  significantly 
accelerates  tube  formation.  Thrombin  and  plasminogen  activator  had  no  apparent  effect. 
Disruption of the largest tubes with trypsin/EDTA permits the cells to revert to a proliferative 
state  if  plated  on  HFN,  in  M-199,  FBS, and  ECGF.  These  observations  indicate  that  culture 
conditions that do  not favor proliferation  permit attainment of  a state of  nonterminal differ- 
entiation  (organization)  by the endothelial cell.  Furthermore,  proteolytic  modification  of the 
HFN  matrix may play an important role in endothelial organization. 
Normal  human  diploid  cells  in  culture  require  serum  as  a 
source of hormones and growth factors for cell division (13). 
The  human  umbilical  vein  endothelial  cell  (HUV-EC)  is  a 
fastidious cell with only limited  proliferative potential  in se- 
rum-supplemented medium (11, 22). Since serum supplies hor- 
mones and growth factors for cell growth in vitro (13, 21, 38), 
it can be argued that serum is deficient in the requisite  hor- 
mone(s)  responsible  for HUV-EC  growth. This  approach to 
HUV-EC growth control has resulted in the identification and 
characterization of an endothelial cell growth factor (ECGF), 
partially purified from bovine hypothalamus (20),  that stimu- 
lates the growth of HUV-EC in vitro (20, 22). In the presence 
of a  human  fibronectin  (HFN)  matrix,  ECGF  permits  the 
growth of HUV-EC at clonal cell densities, reduces the serum 
requirement for HUV-EC growth, and permits the serial prop- 
agation of the  HUV-EC (22).  One can  presently  achieve at 
least  34 cumulative population doublings in an environment 
composed of a  HFN matrix  and medium  199  supplemented 
with ECGF and fetal bovine serum (22). 
In the absence of HFN and ECGF, HUV-EC do not prolif- 
erate beyond 2 or 3 passages. However, under these conditions, 
the cell population actively organizes into three-dimensional 
tubular structures.  Our observations suggest that this organi- 
zational behavior, most readily exhibited by HUV-EC cultures 
maintained under conditions not favoring rapid proliferation, 
may  represent  nonterminal  differentiation  of the  HUV-EC 
population in vitro. 
MATERIALS  AND  METHODS 
Preparation  of Reagents 
Human fibronectin (HFN) was prepared from human Cohn fraction I (Revlon 
Health Care Group, Tuckahoe, NY) as previously described (9). SDS PAGE of 
the purified HFN preparation revealed a single band (5% acrylamide), while SDS 
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cell growth factor (ECGF) was prepared from bovine hypothalamus (Pel-Freeze 
Biologicals, Rogers, AR) as previously described (20). 
All cell culture reagents, including fetal bovine serum (FBS) and Medium 199, 
were obtained from Gibeo Laboratories (Grand  Island Biological Co.,  Grand 
Island, NY). Human alpha-thrombin and plasminogen were kind gifts of Dr. D. 
Bing (Center for Blood Research,  Boston,  MA).  Human kidney plasminogen 
activator (55,000 dalton, urokinasellke  form) was kindly supplied by Dr. Rydichi 
Naito (Green  Cross Corp.,  Osaka, Japan).  Goat  anti-human urokinase (UK) 
antiserum was provided by Dr. F. Booyse (Michael Reese Research Foundation, 
Chicago, IL). Fluorescein-conjugated rabbit anti-human factor VIII-related an- 
tigen (f-Vlll:Ag) antiserum was purchased from Atlantic Antibodies (Scarbor- 
ough, ME) and rabbit anti-human HFN antiserum was obtained from Collabo- 
rative Research Inc. (Waltham, MA). 
Preparation  and Maintenance of Human 
Umbilical Vein (HUV) Endothelial Cells In Vitro 
Cultures of primary HUV-EC established in the absence of a HFN matrix or 
ECGF supplementation were the generous gift of Dr. M.  Gimbrone (Harvard 
Medical School, Boston, MA). The ceils were harvested by treatment with 0.05% 
trypsin-0.02%  EDTA,  the  trypsin inactivated with  1.25 mg  soybean  trypsin 
inhibitor (Sigma Chemical Co., St. Louis, MO) and plated on a HFN-coated cell 
culture dish (10 pg/cm  2) in Medium  199 supplemented with 20% FBS and  150 
pg ECGF/ml. The HUV-EC were routinely grown and passaged in this system 
for at least 34 cumulative population doublings. At various passage levels, HUV- 
EC were collected and stored frozen in liquid nitrogen in the growth medium 
containing 10% glycerol. 
Immunofluorescence and Transmission 
Electron Microscopy 
Immunofluorescent staining of HUV-EC for endothelial cell-derived antigens 
was performed  on cell monolayers that were fixed in methanol for 5  rain at 
-20°C and rinsed with phosphate buffered saline (PBS). The cells were incubated 
with either the appropriate fluorescein-conjugated or nonconjugated  antibody 
(FITC-Anti-f-VIII:Ag,  1:40 dilution; Anti-HFN,  1:20 dilution; Anti-UK,  1:20 
dilution) for 45 min at 25°C. In the case of the non-FITC-conjugated antibodies, 
the specimens were washed three times with PBS and the appropriate FITC- 
conjugated second antibody added (Atlantic Antibodies) for 45 min at 25 °C. The 
specimens were again washed three times with PBS and mounted with buffered 
glycerol under glass cover slips. The cells were examined with a reflected Nikon 
epiilumination  system. Human umbilical  cord frozen sections and normal human 
melanocytes served as positive and negative controls. 
Evaluation of the HUV-EC by electron microscopy was performed by washing 
the cell culture dish and fixing the specimen in the cell culture dish with 2.5% 
gluteraldehyde in 100 mM cacodylate buffer, pH 7.4. Specimens for transmission 
electron microscopy were fLxed for  1 h  in the fixative buffer, postfixed in  10% 
osmium tetroxide buffered with cacodylate and then stained en bloc with  1% 
uranyl  acetate  for  30  min.  The  samples were  dehydrated  through  ethanol, 
embedded  in  Epon-812  and  l-pro  thick sections prepared  and  stained  with 
tohiidine blue. Thin sections were stained with uranyl acetate and lead citrate 
and examined with a Phillips 300 electron microscope (31 ). 
RESULTS 
Organizational Behavior of HUV-EC In Vitro 
The use  of HFN and  ECGF  significantly delays the  pre- 
FIGURE  1  Phase-contrast photomicrograph of organized HUV-EC  population.  Primary cultures of  HUV-EC were digested with 
trypsin and split into plastic cell culture dishes at a 1:5 split ratio. The culture was supplemented with Medium 199 containing 20% 
FBS. The culture  was fed every 2-3  d  for a  period of -2  mo.  At this time, white,  bulbous treads were macroscopically visible. 
Overlapping phase-contrast photomicrographs were taken  (x  250).  A  linear collage of  the phase-contrast photomicrograph  is 
presented. Note the complex weblike structures attached to the surface of the culture dish and the large threadlike structure (not 
focused) that is floating longitudinally above the surface of the dish and is attached at one end of the cell culture dish. Also note 
the dramatic change in diameter and the presence of a dark luminal interior in the floating tubular structure. 
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EC organized structures with anti-human fac- 
tor VIII:Ag, plasminogen activator and fibro- 
nectin. The weblike tubular HUV-EC-derived 
array  was  stained  for  the  human  f-Vlll:Ag, 
p[asminogen activator and fibronectin as de- 
scribed  in  Materials  and  Methods:  (A)  orga- 
nized  HUV-EC  stained  with  anti-human  f- 
VIII:Ag, (B) anti-human fibronectin, and (C) 
anti-human  kidney plasminogen activator, x 
250. 
MACIAG ET AL.  Organizational Behavior of Endothelial  Cells  513 FIGURE  3  Transmission electron microscopy of the HUV-EC organized structures. The tubular array was processed for transmission 
electron microscopy as described in Materials and Methods.  (A)  Cross-section through the weblike HUV-EC organized network. 
Note that the lumen  is composed of a single  HUV-EC  and the luminar space is composed of amorphous and fibrillar debris,  x 
2,800. (B)  Higher magnification of the tubular structure shown in (A). X 60,000.  Note the presence of distinct WeibeI-Palade body. 
(C)  Higher magnification of the tubular structure observed in  (A).  x  40,000.  Note the interdigitating junctions  (arrow). 
mature  senescence  of HUV-EC  populations  in  vitro.  In  the 
absence  of HFN  and  ECGF,  confluent  HUV-EC  primary 
monolayers could be passaged at least once at a  1:5 split ratio. 
However, the cells routinely failed to achieve confluence after 
the  second passage.  Instead,  the  preconfluent cells began  to 
migrate into clusters and, after ~4-6 wk in culture, had formed 
a complex network of tubular structures (Fig. 1). Under phase- 
contrast microscopy, the network was arranged as branching 
strands that varied in diameter and appeared randomly distrib- 
uted throughout  the  culture dish.  Large areas of the culture 
dish did not contain a cobblestonelike monolayer of HUV-EC. 
The weblike network appeared to contain a lumen, as indicated 
by the accumulation of amorphous debris within these struc- 
tures. After ~7-8 wk in culture, the tubular array became large 
enough  to  be grossly visible as white,  threadlike strands.  In 
some  cases,  individual  strands  partially detached  from  the 
surface of the culture dish and floated in the medium remaining 
attached to the culture dish at either one or both ends of the 
structure (Fig. 1). These large tubelike structures also varied in 
diameter and contained much debris within their lumens. 
Endothelial Nature of the Organized Structures 
The weblike network was assessed for endothelial cell char- 
acter by immunofluorescent staining. As shown in Fig. 2A, the 
tubular structures stained positive with anti-human f-VIII:Ag. 
We were also able to determine that the change in HUV-EC 
morphology from the  conventional cobblestone pattern to  a 
spindle-shaped pattern (Fig. 5A and B) occurred without the 
loss of the  human  f-VIII:Ag marker.  The  tubular structures 
also stained positive with antiserum to human fibronectin and 
human urokinaselike plasminogen activator (Fig. 2 B and C). 
The  endothelial nature  of the  tubular  structure  was  con- 
firmed by transmission electron microscopy (Fig. 3).  Exami- 
nation of the surface-attached tubular element by transmission 
electron  microscopy revealed that  the  circumference  of the 
lumen was formed by a single HUV-EC (Fig. 3A). The border 
of the endothelial cell was held together by a junction com- 
posed of interdigitating extensions of the cytoplasm (Fig. 3 C). 
The presence of Weibel-Palade bodies in the cytoplasm of the 
tubular structures was also noted (Fig. 3 B). Large amounts of 
amorphous and granular debris are also clearly visible in the 
channel area of the tube (Fig. 3A and C). 
The Reversible Nature of HUV-EC Organization 
To  determine whether the  HUV-EC  present  as  organized 
structures  are  capable  of proliferating in  vitro,  the  floating 
multicellular  macroscopic tubular structures were mechanically 
removed  from  the  cell culture dish and  washed  three  times 
with Dulbecco's phosphate-buffered saline. The intact structure 
was digested with trypsin-EDTA and the single-cell  suspension 
plated onto a  HFN matrix in the presence of 20%  FBS and 
ECGF (150 #g/ml). The HUV-EC  processed in this manner 
grew  to  confluence  and  were  positive  for  human  f-VIII:Ag 
(Fig. 4A and B). We also observed that the HUV-ECs could 
be grown from the tubelike structure as an explant under cell 
culture  conditions  optimized  for  HUV-EC  attachment  and 
growth. 
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anti-human  factor  Vlll:Ag  immunofluores- 
cence of HUV-EC derived from the organized 
structure.  A  floating,  macroscopic  tubular 
structure  was  removed  from  the  organized 
HUV-EC  population.  The  tube  was  washed 
with  Medium  199  and  digested  with  0.05% 
trypsin-O.02%  EDTA  for  10  min  at 37°C.  The 
trypsin was  inactivated with  soybean trypsin 
inhibitor (250/~g/ml) and a single-cell suspen- 
sion  created from  the tubular structure.  The 
tube-derived  single-cell  suspension  was 
plated on a  HFN  matrix (10/.tg/cm 2)  and the 
culture  fed  20%  FBS and  ECGF  (150 ~g/ml). 
(A)  Phase-contrast morphology of the mono- 
layer derived from the floating tubular struc- 
ture.  Note  the  presence  of  the  classic  large 
vessel endothelial cell morphology x  200. (B) 
Immunofluorescence  of  the  tube-derived 
monolayer with anti-human factor VIII:Ag.  x 
1,000. 
Are Confluent HUV-EC Cultures Capable 
of Organization ? 
HUV-EC  cultures were  grown on  a  plastic surface in  the 
presence of 20% FBS and 150/~g/ml ECGF. After confluence, 
ECGF was removed from the growth medium and the cultures 
were fed Medium  199 containing 20% FBS every 2-3 d  for a 
period of 2  mo.  We observed, after  1-2 wk,  the  presence of 
spindle-shaped HUV-EC which appeared to be migrating out 
of the typical endothelial cell cobblestone pattern (Fig. 5A). 
This event was called Stage I behavior. After 2-3 wk in culture, 
a majority of the HUV-EC became migratory and the culture 
had lost its cobblestone pattern (Fig. 5 B).  At that time, the 
migrating HUV-EC  aggregated around debris that had accu- 
mulated on the surfaces of the aligned cells (Fig. 5 B). These 
events were termed Stage II behavior. After 3-4 wk in culture, 
the migratory HUV-EC formed a channel of aligned endothe- 
lial cells with debris at the end of the structure (Fig. 5 C). At 
that time, the presence of a small lumen became visible in the 
center of the channel of the aligned endothelial cells (Fig. 5 D, 
Stage  III behavior).  After  5-6  wk  in  culture,  the  HUV-EC 
organized structure became weblike with an exaggerated hon- 
eycomb  pattern  (Fig.  1,  Stage  IV).  Large  areas  of the  cell 
culture  dish  were  free  of  endothelial  cells.  The  HUV-EC 
tubular structures increased in diameter so that after ~7-8 wk 
in culture, the tubes became grossly visible (Fig. 5 E).  These 
debris-containing structures  lifted off the  surface of the  cell 
culture dish, even in those cases in which branch points were 
apparent (Fig. 5 F). This event was termed Stage V behavior. 
The  morphological changes  during  the  Stage  I  to  Stage  V 
transition are summarized in Table I. 
The morphological events leading to HUV-EC tube forma- 
tion (Stage I through Stage V) also occurred in confluent HUV- 
EC cultures grown on a HFN matrix in the presence or absence 
of ECGF.  Under these conditions, HUV-EC  tube formation 
occurred  only after  a  delay of ~2-3  wk when  compared to 
HFN-free, ECGF-free, control cultures. 
The Role of Extracellular Matrix in HUV- 
EC Organization 
Because  (a)  the  addition  of gCOF  delayed  but  did  not 
prevent  HUV-EC  organization  and  (b)  the  morphological 
events leading to HUV endothelial cell alignment appeared to 
be primarily migratory, the role of the HUV-EC extracellular 
matrix  was  examined  as  a  possible  mediator  of  HUV-EC 
MACIAG  [r  At.  Organizational Behavior of Endothelial Cells  515 FIGURE  5  Organizational  behavior of  a  confluent  monolayer of  HUV-EC.  HUV-EC  (Passage 5)  were grown  to  confluence  in 
Medium  199 containing 20% FBS and ECGF (150 p,g/ml) on a HFN  matrix (10/Lg/cm2). After confluence (3.5 x  104 HUV-EC/cm~), 
the culture was fed every 2-3 d with Medium 199 and 20% FBS. The organizational process was monitored over a period of 2 too. 
The magnification of the phase-contrast photomicrographs is x  250. (A) Appearance of the HUV-EC monolayer 1-2 wk after the 
removal of ECGF. Note the appearance of migratory HUV-EC (arrows) indicative of Stage I behavior. (B) Appearance of the HUV- 
EC monolayer after 2-3 wk. Note the loss of the cobblestone morphology and the appearance of predominant migratory cells. This 
morphology is termed Stage  II  behavior. Also note the appearance of aligned cells with  the accumulation of debris on the cell 
surface.  (C)  HUV-EC monolayer 3-4 wk after ECGF withdrawal. Note the formation of a channel and the appearance of a lumen. 
This morphology is termed Stage  III  behavior. Note also that the debris associated with  Stage  II  morphology is still  present. The 
number of HUV-EC present at this time was estimated to be 2.7 x  104 HUV-EC per cm  2. This represents approximately a 20% loss 
of  HUV-EC  over 25 d  in  culture  in  the absence of  ECGF. (D)  Appearance of  the  HUV-EC  monolayer after 5-6  wk.  Note the 
formation  of  an  exaggerated weblike structure  on  the surface of  the dish  and  the  loss of  single endothelial cells  around  the 
honeycomb pattern. This morphology is indicative of Stage IV behavior. (E and  F)  HUV-EC monolayer 7-8 wk in culture after the 
removal of ECGF. Note the appearance of macroscopic tubular forms floating  in the dish and the presence of debris inside the 
tubular structure. The appearance of the threadlike structures  is termed Stage V  behavior. Also note the appearance of floating 
tubes complete with  branch  points. The honeycomb pattern  is still  visible on  the surface of  the cell dish  but  is  not  in  focus. 
Compare the morphology shown in Fig. 1 (Stage IV and V behavior) with these transitional changes. 
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Summary of the Morphological Events During the 








III  4 
IV  5-6 
V  6 
Morphological changes 
Increased incidence of migratory human factor 
VIII:Ag positive HUV-EC. 
Aggregation of  migratory cells to form  small 
channels.  Appearance of  accumulated  cell 
surface debris is apparent. 
Alignment  of  HUV-EC  with  growth  of  the 
channel. Appearance of visible lumen. 
Development of an organized weblike pattern 
with an exaggerated honeycomb pattern. 
Elongation  of  macroscopic  floating  tubular 
structures attached to the surface of the dish 
at one or both ends. 
See Figs. 1 and 5 for morphological correlates during the transitional changes. 
organization. Confluent monolayers of HUV-EC were digested 
with 0.25% trypsin for 10 re_in at 37°C. The cells were removed 
from the culture dishes and the trypsin inhibited with 2.5-mg 
soybean trypsin inhibitor. The cells were recycled back into the 
trypsin-treated cell culture dishes at a split ratio of 1:5 and fed 
Medium 199 and 20% FBS. The endothelial cells responded to 
trypsin digestion of the HUV-EC-derived extracellular matrix 
by organizing into Stage III structures after ~ 1 wk in culture, 
representing a fourfold decrease in the time ordinarily required 
to generate Stage III behavior.  This phenomena occurred in 
approximately 6 out of 10 cases. 
A similar response was also observed using a trypsin-digested 
HFN matrix. Purified HFN was plated onto the surface of cell 
culture dishes at a concentration of 10 #g/cm  2. The matrix was 
digested with 0.25% trypsin for 10 min at 37°C and the trypsin 
inhibited  with  2.5-mg soybean trypsin inhibitor/ml.  We ob- 
served  the  same  fourfold  decrease  in  the  time  required  to 
generate Stage III behavior (Fig. 6 E). This phenomenon oc- 
curred with approximately the same frequency as observed for 
the trypsin-digested HUV-EC-derived extracellular matrix. 
Because these results suggested that proteolytic modification 
of HFN by trypsin is important in increasing the rate of HUV- 
EC organization, other more physiologically relevant proteases 
were assessed for their ability to achieve the same effects as 
trypsin. Replicate HFN-coated cell culture dishes were treated 
(37°C,  1 h) with alpha-thrombin,  plasminogen, plasminogen 
activator, or plasmin. HUV-EC plated on a HFN matrix altered 
with plasminogen activator or plasmin formed tubular struc- 
tures at a markedly increased rate (Fig. 6A, B,  C, D, and E). 
In contrast, alpha-thrombin and plasminogen did not augment 
the rate of HUV-EC organization on a HFN matrix. Further- 
more,  plasminogen  activator  and  plasmin  had  no  effect  on 
HUV-EC tube formation in the absence of HFN. 
DISCUSSION 
The luminal lining of blood vessels consists of a monotonous 
continuum of nonthrombogenic endothelial cells that possess 
a low mitotic index in vivo (1, 41). Disruption of  the endothelial 
continuum  with  proteolytic  enzymes  in  a  selective  manner 
provides access to the endothelial cell for cultivation in vitro 
(10). The introduction of the proteolytically removed endothe- 
lial cell population into an environment consisting of a  HFN 
matrix  in Medium  199  supplemented  with  FBS  and  ECGF 
maximizes  the  proliferative  potential  of the  endothelial  cell 
culture (22).  Such an environment provides the requisite  at- 
tachrnent and mitogenic stimuli for the serial propagation of 
normal  and  genetically  variant  HUV-EC  in  vitro  (2,  22). 
Repeated exposure of the HUV-EC to this environment results 
in the proliferative senescence of  the endothelial cell population 
after  approximately  34-45  cumulative  population  doublings 
(22).  Conventional HUV-EC culture in the absence of HFN 
and  ECGF  leads  to  premature  senescence  of the  HUV-EC 
population  after  approximately  3-5  cumulative  population 
doublings (2, 10, 11, 29). Cultivation of the conventional HUV- 
EC cultures in Medium  199 and FBS for a period of 4-6 wk 
results in the appearance of organized HUV-EC structures. We 
have  characterized  the  organizational  process  of HUV-EC 
behavior to represent a process of nonterminal HUV-EC dif- 
ferentiation. 
The organizational behavior of HUV-EC can be observed 
under a variety of circumstances, that include (a) removal of 
ECGF  from  a  confluent  monolayer,  (b)  plating  HUV-EC 
populations in the absence of HFN and ECGF, and (c) pro- 
viding requisite matrix-derived signals for HUV-EC organiza- 
tion.  In  all  instances,  HUV-EC  organization  occurs  in  an 
environment in which the proliferative potential of the HUV- 
EC population is minimized. Under these conditions HUV-EC 
tube formation occurs relatively rapidly in preconfluent cul-" 
tures. The addition of either an intact HFN matrix or ECGF 
to the culture environment did not prevent, but significantly 
delayed the  process of HUV-EC organization.  The ceils  in- 
volved in  tube  development  were  endothelial  cells  and  not 
smooth  muscle  cell  contaminants,  as  the  tubular  structures 
contained the factor VIII:Ag and Weibel-Palade  bodies, two 
markers that are specific for endothelial cells (15, 36). Further- 
more, ceils derived  from tubular  structures  by either trypsin 
digestion  or  tube  explant  methods  grew  to  form  a  classic 
cobblestone endothelial  cell monolayer and contained factor 
VIII:Ag. 
The ability of the endothelial cells that were organized into 
tubular structures to revert to a proliferative state under con- 
ditions that were optimal for HUV-EC growth suggests that 
these organized ceils were in a state of nonterminal differentia- 
tion.  This concept is described in model form in Fig. 7. The 
reciprocal relationship between HUV-EC growth and organi- 
zation is a concept that has been described in other differen- 
tiating  cellular systems including the smooth muscle cell (3) 
and megakaryocyte (37). The ability of the HUV-EC to orga- 
nize independently of cumulative population doublings under 
culture conditions that minimize proliferation emphasizes the 
reciprocity  between  growth  and  organization.  It  will  be  of 
interest  to  determine  whether  the  process  of organizational 
behavior influences HUV-EC senescence in vitro. 
The process of HUV-EC organization has been divided into 
five stages.  It is apparent from phase-contrast and time-lapse 
photomicrographs (Kadish,  J.,  and  T.  Maciag,  unpublished 
observations) that the initial event in the organizational process 
involves migration of the endothelial cell (Stage I). The migra- 
tory HUV-EC aggregate, accumulate cell-surface debris (Stage 
II) and align in a manner conducive to lumen formation (Stage 
III). Although the mechanism of lumen formation is not pres- 
ently clear, the appearance of luminal debris suggests that the 
aligned HUV-EC use the cell-surface debris and neighboring 
cells  as a  scaffolding, such that podia are extended over the 
debris to form single cell junctions. The appearance of base- 
ment  membranelike  material  in  the  lumen  of these  three- 
dimensional structures also suggests that if a nonthrombogenic 
surface is expressed  by the HUV-EC organized structures,  it 
MACIAG I~T At.  Organizational  Behavior  of Endothelial Cells  517 FIGURE  6  Enhancement of HUV-EC organizational behavior by proteolytic modification of fibronectin.  Plastic cell culture dishes 
were coated with  purified  HFN  (10/~g/cm2).  Duplicate  dishes  (n  =  4)  were treated with  a  variety of  proteoiytic enzymes in 
Dulbecco's phosphate buffered saline. The proteolytic enzymes included trypsin (1.0/zg/ml), human kidney plasminogen activator 
(1.0/.tg/ml),  human  alpha-thrombin  (5/~g/ml),  and  human  plasminogen  (1.8/Lg/ml).  The enzymes were exposed to the  HFN- 
coated surface for 1 h at 37°C (trypsin, 10 min exposure). HFN-free cell culture dishes and protease-treated HFN-free cell culture 
dishes served as controls. HUV-EC (passage 6) were added to each dish at a seed density of 2 x  10  4 cells/cm 2 and the cultures fed 
10% FBS and Medium 199 every 2-3 d. The cultures were assessed for Stage JII behavior in a blind fashion after I  wk in culture and 
phase-contrast photomicrographs (x 250)  taken. (A)  H FN: protease-free control, (B)  H F  N and plasminogen, (C)  H FN and alpha- 
thrombin, (D)  HFN and plasminogen activator, (E)  HFN and plasmin (plasminogen activator plus plasminogen), and (F)  HFN and 
trypsin. Note the appearance of Stage III behavior (arrows) in  D,  E, and  F. The HFN-free controls (not shown) were negative. 
may indeed be on the outside surface of the tube (Stemerman, 
M. B., and T. Maciag, unpublished observations). The organ- 
izational  process  continues  to  develop  a  weblike  structure 
(Stage IV). The continuity of  the structure can be demonstrated 
by  injecting  fluorescein  dye  into  the  lumen  under  nitrogen 
pressure, through a micropipette. The dye can be observed to 
be restricted  to the  lumen,  suggesting functional integrity of 
the endothelial cell junctions noted in the transmission electron 
micrographs (Clivden, J., G. A. Hoover, R. Weinstein, and T. 
Maciag, unpublished observations). This capillarylike contin- 
uum further develops until macroscopically distinct white bul- 
bous threadlike structures anchored at either one or both ends 
of the cell culture dish, are readily ascertained (Stage V). It is 
of interest  to note that the  HUV-EC  grown from explanted 
threads morphologically resemble the tightly compacted cob- 
blestone pattern unique to the large vessel endotbelium (29). 
518  THE  JOURNAL OF  CELL BIOLOGY • VOLUME 94,  1982 FIGURE  7  Model  summarizing  the  reciprocity  between  HUV-EC 
proliferation  and  organization.  The endothelium  in  vivo exists as  a 
monolayer of  nonproliferative cells.  Digestion  of  this  monolayer 
with  proteolytic  enzymes  and  the  introduction  of  the  HUV-EC 
population  to  a  growth  factor-rich  environment  (FBS  +  ECGF) 
results in cell proliferation. Repetitious subcultivation in the prolif- 
erative environment results in  HUV-EC senescence.  However, the 
HUV-EC  population can  be  induced  to  form  complicated  three- 
dimensional structures at any point in the in vitro aging process by 
removal of HFN  and  ECGF after the subculture. Similar results can 
also be obtained with  confluent  HUV-EC cultures.  The organized 
structures represent a form of HUV-EC nonterminal differentiation 
because the organized  population  can  revert  into  a  proliferative 
compartment by treatment with proteolytic enzymes and the intro- 
duction of a growth-stimulating environment. 
These studies confirm and extend the observations of Folk- 
man  and  Haudenschild  (8)  concerning capillary-derived en- 
dothehal cell behavior in vitro. The structures formed by the 
HUV-EC organizational process are morphologically consist- 
ent with the three-dimensional structures that have been de- 
rived from confluent cultures of human capillary endothelial 
cells (8). In addition, our observations concerning the transition 
from Stage I to Stage IV development agree with the morpho- 
logical events associated with capillary angiogenesis in  vitro 
(8). 
We have attempted to elucidate the mechanism responsible 
for the process of HUV-EC  organization. Our data strongly 
suggest that  the rate of transition from  Stage  I  to  Stage IV 
morphology is strongly influenced by proteolytic modification 
of the extracellular matrix. It is also apparent from these studies 
that  the  extracellular  matrix  is  a  source  of proteolytically 
modified HFN as a  mediator of this process because trypsin 
and plasmin-modified HFN substitute for the HUV-EC extra- 
cellular matrix and increase the rate of the Stage I to Stage III 
organizational transition. 
The  ability of plasmin  to  initiate  these  events  via  HFN 
modification represents an observation that is consistent with 
mechanisms proposed for normal and tumor angiogenesis. It 
is established that HFN provides an efficient attachment sur- 
face for mammalian ceils in culture (9,  21, 27, 38), including 
the HUV-EC (22).  Plasminogen activator is a  serine protease 
that has been implicated in a  wide variety of developmental 
and pathophysiological systems including embryogenesis (33), 
ovulation  (32),  wound  healing  (18),  tissue  remodeling (12), 
tumor invasiveness (34) and growth (17, 24), and the migratory 
behavior of mammalian cells such as the macrophage (12). In 
addition, purified plasminogen activator and heparin as well 
as fibrin and  fibrin digestion products  have  been  shown  to 
markedly  stimulate  angiogenesis  in  vivo  (4,  6,  7,  25,  27). 
Furthermore,  HFN  and  proteolytically modified  HFN  are 
chemotactic for mammalian cells in vitro (30,  35)  and  HFN 
possess a binding site for heparin (23, 27). The suggestion that 
fibrin provides a scaffold for cell growth (39) is an observation 
consistent with the report that HFN is covalently cross-linked 
to fibrin by factor-XIII (23)  and  that  fibrin deposition and 
fibrinolysis are events important to wound  healing (28)  and 
tumor growth (6, 7,  14, 25, 26, 40). In addition, the HUV-EC 
is capable of synthesizing plasminogen activator (19) and HFN 
(16).  It is therefore not surprising that delayed HUV-EC or- 
ganization occurs in vitro in a  serum-supplemented environ- 
ment, because serum is a potential source of plasminogen. The 
enhancement of HUV-EC tube formation by a HFN-depend- 
ent flbrinolytic system strongly argues that the HUV-EC  or- 
ganizational process involves the activation of latent matrix- 
derived signals by specific proteolytic enzyme systems. It is of 
interest to note that plasmin-derived fragments of HFN contain 
transformation-enhancing  activity in  chicken  embryo  fibro- 
blasts infected with Rous sarcoma virus (5). 
The HUV-EC organized structure represents an alternative 
model for the study of endothelial cell development and tumor 
angiogenesis in vitro (8).  Although it has been suggested that 
ECGF and tumor-conditioned medium are required for cap- 
illary angiogenesis in culture (8), our studies demonstrate that 
HUV-EC organization routinely occurs in an environment that 
limits HUV-EC  growth.  It  is  possible that  the  addition  of 
tumor-conditioned medium to the endothelial cell culture may 
increase the rate of HUV-EC organization in a manner similar 
to the effect observed with trypsin and plasmin-modified HFN. 
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